Literature DB >> 34156590

A Decreased Response to Resistin in Mononuclear Leukocytes Contributes to Oxidative Stress in Nonalcoholic Fatty Liver Disease.

Cecilia C Garcia1, Bárbara Piotrkowski2,3, Plácida Baz1, Daniel Poncino4, Javier Benavides5, Luis Colombato5, María Laura Reyes Toso6,7, Silvina Yantorno6,7, Valeria Descalzi6,7, Gabriel E Gondolesi6,7, Cesar G Fraga2,3, Alejandra C Cherñavsky8.   

Abstract

BACKGROUND: Deregulation of immune response and oxidative stress contribute to nonalcoholic fatty liver disease (NAFLD) pathogenesis. Resistin is a physiological modulator of inflammation and redox homeostasis of different cell types. Increased resistin serum concentration and the direct association between resistin hepatic expression and NAFLD severity suggest that resistin participates in NAFLD pathogenesis. AIMS: To evaluate resistin-induced regulation of redox homeostasis in mononuclear leukocytes from NAFLD patients and controls.
METHODS: We evaluated basal and resistin-mediated modulation of reactive oxygen species (ROS) and glutathione content by flow cytometry, and antioxidant enzyme activities by spectrophotometry.
RESULTS: Peripheral blood mononuclear cells (PBMC) from NAFLD patients showed higher ROS content and glutathione peroxidase activity and lower glutathione content, superoxide dismutase and glutathione reductase activities than control PBMC. Resistin decreased ROS levels and superoxide dismutase activity and increased glutathione reductase and catalase activities in PBMC from controls but not from patients. Resistin decreased glutathione content in PBMC from control and NAFLD patients, with greater effect on patient cells. Basal and resistin-modulated ROS levels were directly associated with obesity-related risk factors for NAFLD. Hepatic myeloid cells and T-lymphocytes from NAFLD patients showed higher basal ROS content than cells from controls. Resistin decreased ROS levels in hepatic T-lymphocytes from controls but not from patients.
CONCLUSIONS: Resistin regulates redox homeostasis in mononuclear leukocytes. A decreased response to resistin in leukocytes from NAFLD patients is associated with an impaired redox homeostasis.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Antioxidants; Fatty liver; Glutathione; Reactive oxygen species

Mesh:

Substances:

Year:  2021        PMID: 34156590     DOI: 10.1007/s10620-021-07105-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  36 in total

Review 1.  Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies.

Authors:  L Li; D-W Liu; H-Y Yan; Z-Y Wang; S-H Zhao; B Wang
Journal:  Obes Rev       Date:  2016-03-28       Impact factor: 9.213

Review 2.  Nonalcoholic fatty liver disease.

Authors:  Paul Angulo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

3.  The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology.

Authors:  Naga Chalasani; Zobair Younossi; Joel E Lavine; Anna Mae Diehl; Elizabeth M Brunt; Kenneth Cusi; Michael Charlton; Arun J Sanyal
Journal:  Gastroenterology       Date:  2012-05-15       Impact factor: 22.682

Review 4.  Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis.

Authors:  Herbert Tilg; Alexander R Moschen
Journal:  Hepatology       Date:  2010-11       Impact factor: 17.425

5.  Steatohepatitis: a tale of two "hits"?

Authors:  C P Day; O F James
Journal:  Gastroenterology       Date:  1998-04       Impact factor: 22.682

6.  Resistin protection against endogenous Aβ neuronal cytotoxicity from mitochondrial pathway.

Authors:  Jie Liu; Nan Chi; Hongguang Chen; Jingyuan Zhang; Yusong Bian; Guangqiang Cui; Chunming Xiu
Journal:  Brain Res       Date:  2013-06-06       Impact factor: 3.252

Review 7.  Oxidative Stress as a Critical Factor in Nonalcoholic Fatty Liver Disease Pathogenesis.

Authors:  Schohraya Spahis; Edgard Delvin; Jean-Michel Borys; Emile Levy
Journal:  Antioxid Redox Signal       Date:  2016-08-30       Impact factor: 8.401

8.  Resistin inhibits essential functions of polymorphonuclear leukocytes.

Authors:  Gerald Cohen; Dalibor Ilic; Jana Raupachova; Walter H Hörl
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

9.  New evidence for the therapeutic potential of curcumin to treat nonalcoholic fatty liver disease in humans.

Authors:  María Eugenia Inzaugarat; Elena De Matteo; Placida Baz; Diego Lucero; Cecilia Claudia García; Esteban Gonzalez Ballerga; Jorge Daruich; Juan Antonio Sorda; Miriam Ruth Wald; Alejandra Claudia Cherñavsky
Journal:  PLoS One       Date:  2017-03-03       Impact factor: 3.240

View more
  2 in total

Review 1.  Adipokines in Non-Alcoholic Fatty Liver Disease: Are We on the Road toward New Biomarkers and Therapeutic Targets?

Authors:  Vera Francisco; Maria Jesus Sanz; José T Real; Patrice Marques; Maurizio Capuozzo; Djedjiga Ait Eldjoudi; Oreste Gualillo
Journal:  Biology (Basel)       Date:  2022-08-19

2.  Association of ANGPTL8 and Resistin With Diabetic Nephropathy in Type 2 Diabetes Mellitus.

Authors:  Mengni Li; Rongping Fan; Xuemin Peng; Jiaojiao Huang; Huajie Zou; Xuefeng Yu; Yan Yang; Xiaoli Shi; DeLin Ma
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-15       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.